sftd

Caraco Pharma's Generic Paxil®, Approved by the FDA

Filed in archive News , Treatment on July 7, 2007

Paxil.jpg
Paxil® (Paroxetine HCl) - a registered trademark of GlaxoSmithKline - is a psychotropic drug indicated for the treatment of major depressive disorder, panic disorder, obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder.

Now, a generic bioequivalent of the product has been approved by the FDA: Caraco Pharmaceuticals Laboratories, Ltd.'s paroxetine hydrochloride tablets, USP (Paroxetine HCl).

According to Daniel H. Movens, Caraco's Chief Executive Officer:

"We are pleased to gain this approval as it complements our portfolio and fortifies our product offering by expanding our product line. We plan to market this product to the generic pharmaceutical market immediately. This will bring our total product selection to 34 different products represented by 70 various strengths."


Read the full report.

[Photo Credit: MSNBC]


Permalink: Caraco Pharma's Generic Paxil®, Approved by the FDA

Tags: psychotropic  drug  Paxil®  Paroxetine  HCl  generic  drug    contact  contact+lenses 

Vote for Caraco Pharma's Generic Paxil®, Approved by the FDA:

  • Currently 7.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.00 out of 1 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Allergies   Alzheimer's Disease   Arthritis   Bacteria and Bacterial Infections   Best of   Blog Carnivals   Bone Health   Cancer   Cardiovascular Health   Cases   CFS   Consumer Alert   Controversies   Dental Health   Diabetes   Diagnostics   Diarrhea   Did you know   Diet   Dietary Supplements and Vitamins